Mimrylo Kit
Product Images NDC 63020-765

Product Visual Gallery

This gallery contains 48 technical images submitted to the FDA as part of the official labeling for Mimrylo (NDC 63020-765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chemical Structure)

Chemical structure diagram of rusfertide, the active ingredient in MIMRYLO. The image depicts the peptide sequence and associated molecular groups of rusfertide as shown in the product data.*

FDA Label Image

Logo (Logo)

FDA Label Image

Logo (Logo1)

FDA Label Image

Principal Display Panel (NDC 63020-710-10)

Label for MIMRYLO (rusfertide) 9.5 mg per vial, a human prescription drug kit by Takeda Pharmaceuticals America, Inc. The label specifies subcutaneous administration, single-dose vial, reconstitution prior to use, and disposal instructions for unused portions. It includes the NDC 63020-710-10 and dosage details.*

FDA Label Image

Principal Display Panel (NDC 63020-720-20)

Label for Mimrylo (rusfertide) for injection, showing 19 mg per vial dosage. It is indicated for subcutaneous use and is a single-dose vial to be reconstituted prior to use. The label includes Takeda Pharmaceuticals America, Inc. as the labeler, with instructions to discard unused portions. The NDC number 63020-720-20 and a barcode are also visible.*

FDA Label Image

Principal Display Panel (NDC 63020-730-30)

Mimrylo (rusfertide) for injection label showing a 28 mg per vial dosage for subcutaneous use. The label notes it is a single-dose vial meant to be reconstituted prior to use. The label includes the Takeda Pharmaceuticals America, Inc. logo and displays the NDC 63020-730-30, along with placeholders for lot and expiration dates.*

FDA Label Image

Principal Display Panel (NDC 63020-740-40)

Label for MIMRYLO (rusfertide) injection kit, subcutaneous use by Takeda Pharmaceuticals America, Inc. The label shows MIMRYLO 41 mg per vial, single-dose vial with instructions to reconstitute prior to use and discard unused portion. The label includes NDC 63020-740-40 and a barcode.*

FDA Label Image

Principal Display Panel (NDC 63020-760-60)

Label for Mimrylo (rusfertide) 54 mg vial, a single-dose vial for subcutaneous injection. The label states it must be reconstituted prior to use and unused portion discarded. It includes Rx Only designation and is labeled by Takeda Pharmaceuticals America, Inc. The label also contains lot and expiration date fields.*

FDA Label Image

Principal Display Panel (NDC 63020-600-05)

Label for the Diluent for Mimrylo (rusfertide) injection, a single-dose product. The label includes the NDC 63020-600-05 and indicates Rx Only use. It is manufactured by Takeda Pharmaceuticals America, Inc., located in Cambridge, MA. The label also includes placeholders for lot number and expiration date.*

FDA Label Image

Ifu01 (Mimrylo 08)

Dosage strength labels for MIMRYLO (rusfertide) subcutaneous injection kit by Takeda Pharmaceuticals America, Inc., showing five dosage options: 9.5 mg, 19 mg, 28 mg, 41 mg, and 54 mg. Each strength is displayed in a distinct colored box: blue, green, purple, yellow, and black respectively.*

FDA Label Image

Ifu02 (Mimrylo 09)

Illustration of components of the MIMRYLO rusfertide subcutaneous administration kit, showing a medicine vial containing powdered medicine with a cap, and a diluent syringe labeled with parts including cap, liquid diluent, gray plunger, finger flange, body, and plunger rod.*

FDA Label Image

Ifu03 (Mimrylo 10)

An instructional illustration showing components of a subcutaneous injection kit for MIMRYLO (rusfertide). It depicts a vial adapter (13 mm) with a spike, a needle (27-gauge, 1/2 inch) with a needle shield and cap, alcohol swabs, cotton ball/gauze or adhesive bandage, and a sharps container for safe disposal.*

FDA Label Image

Ifu04 (Mimrylo 11)

An instructional illustration showing a rectangular box with a shaded stripe and a label indicating to "Store at Room Temperature." This image appears to provide storage instructions for the product MIMRYLO rusfertide kit.*

FDA Label Image

Ifu05 (Mimrylo 12)

An illustration showing two hands being washed under running water from a faucet, accompanied by the instruction 'Wash Hands.' This diagram visually emphasizes proper handwashing technique.*

FDA Label Image

Ifu06 (Mimrylo 13)

An instructional illustration depicting a rectangular kit box for MIMRYLO (rusfertide), showing where the dosage strength in milligrams and the expiry date (formatted as YYYY-MMM) are indicated on the packaging.*

FDA Label Image

Ifu07 (Mimrylo 14)

An illustration showing two components of a medical kit: a diluent syringe labeled 'Diluent Syringe' and a medicine vial labeled 'Medicine Vial'. The syringe is depicted with a clear barrel and a plunger, while the vial has a stopper on top.*

FDA Label Image

Ifu08 (Mimrylo 15)

Illustration showing components of the MIMRYLO rusfertide subcutaneous injection kit by Takeda Pharmaceuticals America, Inc. It includes a vial adapter, needle, alcohol swabs, a cotton ball or adhesive bandage, and a sharps container for safe disposal.*

FDA Label Image

Ifu09 (Mimrylo 16)

Illustration showing a hand removing the flip-off cap from a vial, indicating preparation for subcutaneous administration using the MIMRYLO kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Ifu10 (Mimrylo 17)

An instructional illustration showing a hand wiping the top of a vial with an alcohol swab, demonstrating aseptic technique before vial use. The image is related to preparation steps for subcutaneous injection products such as the MIMRYLO rusfertide kit by Takeda Pharmaceuticals America.*

FDA Label Image

Ifu11 (Mimrylo 18)

Instructional illustration showing hands peeling back a protective film from a small adhesive or medical device component, with an arrow indicating the direction of removal. Likely related to assembly or preparation steps in the use of a subcutaneous injection kit.*

FDA Label Image

Ifu12 (Mimrylo 19)

An instructional illustration showing how to snap the cap onto a syringe or similar device. The left side displays a hand pressing down on the cap with an arrow and 'Snap' to indicate the motion, while the right side shows a correct position checkmark for proper attachment.*

FDA Label Image

Ifu13 (Mimrylo 20)

An instructional illustration showing a hand holding a vial and attaching a vial adapter tip from a separate piece held by another hand. The vial adapter tip is labeled, demonstrating its connection to the vial, likely as part of preparing medication from the MIMRYLO rusfertide kit for subcutaneous use.*

FDA Label Image

Ifu14 (Mimrylo 21)

Illustration showing a hand removing a protective cap from the tip of a syringe, labeled as the 'Syringe Tip.' This image likely instructs users on prepping the syringe for subcutaneous injection.*

FDA Label Image

Ifu15 (Mimrylo 22)

An instructional illustration showing hands manipulating a syringe and vial, with an arrow indicating a twisting motion to attach or detach the syringe. A warning text advises not to push the plunger to avoid spilling the diluent, related to the MIMRYLO rusfertide subcutaneous injection kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Ifu16 (Mimrylo 23)

An instructional diagram showing two hands. The lower hand holds a vial upright on a surface while the upper hand pushes a syringe plunger down, indicating withdrawal or mixing of the vial's contents using the syringe. This relates to preparation steps for MIMRYLO (rusfertide) subcutaneous injection kit.*

FDA Label Image

Ifu17 (Mimrylo 24)

An instructional illustration demonstrating the preparation of a subcutaneous injection. It shows a hand holding a vial and swirling it slowly to dissolve powder completely, accompanied by text instructions.*

FDA Label Image

Ifu18 (Mimrylo 25)

An instructional illustration showing a syringe inserted into a vial with the caption 'Let Vial Sit Until Excess Foam Goes Away.' This image demonstrates a preparatory step for using the MIMRYLO (rusfertide) subcutaneous injection kit from Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Ifu19 (Mimrylo 26)

An instructional illustration showing a hand holding a syringe above a vial, with an arrow pointing from the vial toward an eye, indicating the suggested direction or usage related to a subcutaneous injection process.*

FDA Label Image

Ifu20 (Mimrylo 27)

An instructional illustration showing a person using a syringe to withdraw liquid medication from a vial. One hand holds the vial steady on a flat surface, while the other hand inserts the syringe needle into the vial's rubber stopper, indicated by a downward arrow.*

FDA Label Image

Ifu21 (Mimrylo 28)

An instructional illustration showing hands assembling a syringe with a cartridge. One hand is rotating the syringe plunger or component with an arrow indicating the direction of rotation, while the other hand is holding the syringe barrel. This image likely demonstrates part of preparing the MIMRYLO rusfertide subcutaneous injection kit for use.*

FDA Label Image

Ifu22 (Mimrylo 29)

An instructional illustration showing hands assembling a component with a syringe, demonstrating the connection or preparation of a subcutaneous injection device. The image depicts a step involving pushing or attaching parts together with directional arrows.*

FDA Label Image

Ifu23 (Mimrylo 30)

An instructional illustration showing two hands preparing a subcutaneous injection device. The top hand is twisting to remove a cap from the device, while the bottom hand holds a syringe or injector pen with a visible needle cover, demonstrating preparation steps for administration.*

FDA Label Image

Ifu24 (Mimrylo 31)

Illustration depicting a hand holding a small vial above a red and white medical sharps container with a slot on top, indicating the proper disposal of the vial into the container. This is related to the disposal of components in the MIMRYLO rusfertide subcutaneous injection kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Ifu25 (Mimrylo 32)

An instructional illustration showing hands peeling back the foil packaging of a single prefilled subcutaneous injection device, which includes a needle cover and a plunger, likely part of the MIMRYLO rusfertide injection kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Ifu26 (Mimrylo 33)

An instructional illustration showing two hands preparing a syringe for injection. One hand holds the syringe body while the other hand is removing a cap from the needle. The action is indicated by an arrow showing the direction of cap removal.*

FDA Label Image

Ifu27 (Mimrylo 34)

Image of a MIMRYLO (rusfertide) subcutaneous injection kit by Takeda Pharmaceuticals America, Inc. The kit shows a prefilled syringe with a needle and attached components, intended for human prescription use.*

FDA Label Image

Ifu28 (Mimrylo 35)

An instructional diagram showing recommended injection sites for a subcutaneous drug. The front view highlights the stomach area at least 2 inches away from the navel and both front thighs. The back view shows the outer areas of both upper arms as caregiver use only injection sites.*

FDA Label Image

Ifu29 (Mimrylo 36)

Illustration showing a hand placing or holding a small adhesive bandage on an arm, likely depicting post-injection care for a subcutaneous injection.*

FDA Label Image

Ifu30 (Mimrylo 37)

Instructional illustration demonstrating the proper technique to bend back the needle shield of a subcutaneous injection device. The image shows hands holding the device and peeling the needle shield backward as indicated by an arrow, emphasizing needle safety and preparation for injection.*

FDA Label Image

Ifu31 (Mimrylo 38)

An instructional illustration showing hands removing a cap from the needle end of a syringe. The syringe is partially filled, with a locking safety mechanism attached to the needle, demonstrating preparation for a subcutaneous injection.*

FDA Label Image

Ifu32 (Mimrylo 39)

An instructional illustration showing two hands holding a subcutaneous injection device. The top hand holds the syringe barrel with a dose counter or plunger, while the bottom hand pulls the plunger down, indicated by a black arrow pointing upward. The image likely demonstrates preparation or operation of an injectable kit device.*

FDA Label Image

Ifu33 (Mimrylo 40)

Illustration demonstrating a hand pinching the skin, likely as part of an instructional guide for subcutaneous injection preparation, relevant for use with the MIMRYLO rusfertide subcutaneous injection kit.*

FDA Label Image

Ifu34 (Mimrylo 41)

An instructional diagram showing the proper method for subcutaneous injection using a syringe. The illustration highlights inserting the needle at a 90° angle as correct and a 45° angle as acceptable, demonstrating hand positioning over a body part for injection.*

FDA Label Image

Ifu35 (Mimrylo 42)

An instructional illustration showing a hand pressing down on the plunger of a subcutaneous injection device. The visual emphasizes the action of injecting a medication under the skin, likely related to the administration of the rusfertide-containing kit MIMRYLO by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Ifu36 (Mimrylo 43)

An instructional illustration showing a hand pulling off a cap or cover from a syringe or pen injector device, indicated by a black arrow pointing downward. The drawing focuses on demonstrating how to prepare the device for use.*

FDA Label Image

Ifu37 (Mimrylo 44)

An instructional illustration depicting a hand snapping a component of a medical device or kit. The image likely demonstrates part of the preparation or administration process for the MIMRYLO rusfertide subcutaneous kit from Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Ifu38 (Mimrylo 45)

An instructional illustration showing a hand holding a syringe above a sharps disposal container, with an arrow indicating the syringe should be disposed into the container. The image is related to safe disposal of used syringes, likely associated with subcutaneous injection kits like MIMRYLO.*

FDA Label Image

Ifu39 (Mimrylo 46)

Illustration showing a hand holding a cotton ball or pad against a skin surface, representing preparation or care for a subcutaneous injection site. This image likely serves as an instructional visual related to subcutaneous administration, relevant to MIMRYLO (rusfertide) kit by Takeda Pharmaceuticals America, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.